Literature DB >> 11501466

Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care.

.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11501466      PMCID: PMC81309     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  17 in total

1.  The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Authors:  J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.

Authors:  J S Mandel; T R Church; F Ederer; J H Bond
Journal:  J Natl Cancer Inst       Date:  1999-03-03       Impact factor: 13.506

3.  Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects.

Authors:  J D Hardcastle; W M Thomas; J Chamberlain; G Pye; J Sheffield; P D James; T W Balfour; S S Amar; N C Armitage; S M Moss
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

4.  Screening sigmoidoscopy and colorectal cancer mortality.

Authors:  P A Newcomb; R G Norfleet; B E Storer; T S Surawicz; P M Marcus
Journal:  J Natl Cancer Inst       Date:  1992-10-21       Impact factor: 13.506

5.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

6.  Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis. Results from the Danish Polyposis Register.

Authors:  S Bülow; C Bülow; T F Nielsen; L Karlsen; F Moesgaard
Journal:  Scand J Gastroenterol       Date:  1995-10       Impact factor: 2.423

7.  Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects.

Authors:  J Kewenter; S Björk; E Haglind; L Smith; J Svanvik; C Ahrén
Journal:  Cancer       Date:  1988-08-01       Impact factor: 6.860

8.  Protection by endoscopy against death from colorectal cancer. A case-control study among veterans.

Authors:  A D Müller; A Sonnenberg
Journal:  Arch Intern Med       Date:  1995-09-11

9.  Multiphasic Health Checkup Evaluation: a 16-year follow-up.

Authors:  G D Friedman; M F Collen; B H Fireman
Journal:  J Chronic Dis       Date:  1986

10.  Molecular diagnosis of familial adenomatous polyposis.

Authors:  S M Powell; G M Petersen; A J Krush; S Booker; J Jen; F M Giardiello; S R Hamilton; B Vogelstein; K W Kinzler
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

View more
  75 in total

1.  Primary care--the hard parts.

Authors: 
Journal:  CMAJ       Date:  2001-10-30       Impact factor: 8.262

2.  Colorectal cancer screening: you can't be positive about a negative result.

Authors:  J Hoey; E Wooltorton
Journal:  CMAJ       Date:  2001-10-30       Impact factor: 8.262

3.  Hereditary nonpolyposis colon cancer.

Authors:  E G Lemire
Journal:  CMAJ       Date:  2001-11-13       Impact factor: 8.262

Review 4.  Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening.

Authors:  Linda Rabeneck; R Bryan Rumble; Frank Thompson; Michael Mills; Curtis Oleschuk; Alexandra Whibley; Hans Messersmith; Nancy Lewis
Journal:  Can J Gastroenterol       Date:  2012-03       Impact factor: 3.522

5.  [Colorectal cancer in Germany. Means for prevention and early detection: implications for laiety and physicians].

Authors:  A Eickhoff; C Maar; B Birkner; J F Riemann
Journal:  Internist (Berl)       Date:  2003-03       Impact factor: 0.743

Review 6.  [The importance of rectoscopy and colonoscopy in Internal Medicine].

Authors:  A Eickhoff; J F Riemann
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

7.  Colorectal cancer screening in Canada: it's time to act.

Authors:  Richard E Schabas
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

8.  New grades for recommendations from the Canadian Task Force on Preventive Health Care.

Authors: 
Journal:  CMAJ       Date:  2003-08-05       Impact factor: 8.262

9.  Endoscopic follow-up of positive fecal occult blood testing in the Ontario FOBT Project.

Authors:  Lawrence Paszat; Linda Rabeneck; Lori Kiefer; Verna Mai; Paul Ritvo; Terry Sullivan
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

10.  Resource implications for a population-based colorectal cancer screening program in Canada: a study of the impact on colonoscopy capacity and costs in London, Ontario.

Authors:  Agatha Lau; James C Gregor
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.